MRI for breast cancer screening, diag- nosis, and treatment[ ]1- Lancet,2011,378 : 1804-18ll.Morrow M, Waters, Morris E. MRI for breast cancer screening, diagnosis, and treatment. The Lancet 2011;378(9805):1804-1811.Morrow M, Waters J, Morris E. MRI for breast cancer screening, ...
Understanding the indications for breast MRI, diagnostic criteria utilized to detect and characterize breast cancer, and technical challenges are important in both clinical and research settings. In this chapter we discuss the utilization of breast MRI in breast cancer diagnosis and staging, including ...
方法 The purpose of this study was to develop and evaluate a DL system for predicting the probability of breast cancer in DCE-MRI. To do so, we collected adatasetof 21,537 DCE-MRI examinations from the NYU Langone Health sites. We used it to train,validate, and test the system. In ad...
Goldhirsch 等[12] 在国际乳腺癌会议上建议用乳腺癌的分子分型代替病理分型, 结合ER、PR、HER-2 和Ki-67 增殖指数, 将乳腺癌分为Luminal A 型、Luminal B 型、HER-2 阳性、三阴性(triple negative breast cancer, TNBC) 共4 种分子分型。传统的IH...
Dynamic contrast-enhanced MRI(DCE-MRI) and diffusion-weighted imaging(DWI) have been used for the diagnosis of breast cancer recently,with an apparently high rate of diagnosis.Her-2 and Ki-67 are prognostic factors of breast cancer that have been confirmed to be correlated with histological type...
Improving breast cancer diagnostics with deep learning for MRI 使用深度学习改善乳腺癌诊断的MRI技术 01 文献速递介绍 乳腺磁共振成像(MRI)是一种高度敏感的检测乳腺癌的方式,报道的敏感性超过80%。传统上,其在筛查中的使用被限制在高风险患者身上。新的证据支持在中等风险和普通风险女性中进行筛查MRI的作用4)。诊...
Breast Ultrasound in Pre- and Postoperative Patients. Sonography is supedorio mammography in the detection of recurrences after breast-conserving - surgery with or without the implantation of a prosthesis. During... B Gerlach,W Holzgreve - 《Ultrasound Quarterly》 被引量: 0发表: 1995年 加载更多来...
BitencourtA, GibbsP, Rossi SaccarelliC, et al.MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer[J]. EBioMedicine, 2020, 61:103042...
(HealthDay)—Single-screening breast magnetic resonance imaging (MRI) detects 18.1 additional cancers after negative findings with mammography and ultrasonography (US) per 1,000 women with a history of breast cancer, according to a study published in the
breast cancer diagnosis was 39 years (range 24 to 43 years), and the median latency period between HL diagnosis and age atbreast cancerdiagnoses was 21 years (range 12 to 27 years). "This illustrates the young age at which these cancers can occur. For some of these women, if they had...